Human Fibroblast Activation Protein alpha/FAP Antibody
R&D Systems, part of Bio-Techne | Catalog # MAB3715
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Leu26-Asp760
Accession # Q12884
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human Fibroblast Activation Protein alpha/FAP Antibody
Detection of Fibroblast Activation Protein alpha/FAP in WI‑38 Human Cell Line by Flow Cytometry.
WI-38 human lung fibroblast cell line was stained with Mouse Anti-Human Fibroblast Activation Protein a/FAP Monoclonal Antibody (Catalog # MAB3715, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Phycoerythrin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0102B). View our protocol for Staining Membrane-associated Proteins.Detection of Fibroblast Activation Protein alpha/FAP in U-87 MG cells by Flow Cytometry.
U-87 MG cells were stained with Mouse Anti-Human Fibroblast Activation Protein alpha/FAP Monoclonal Antibody (Catalog # MAB3715, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Fluorescein-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0103B). View our protocol for Staining Membrane-associated Proteins.Detection of Fibroblast Activation Protein alpha /FAP by Immunohistochemistry
The expression of FAP and EGFR and clinical outcome in 132 cases of esophageal cancer. (A) IHC for FAP and EGFR are shown at low and high magnification (40 × and 200 ×). Scale bars: 500 µm (40 ×), 100 µm (200 ×). The expression of FAP and EGFR is different between intra-tumoral and peri-tumoral tissue. (B) Representative example of a low- and high-FAP and EGFR case. Scale bars: 200 µm (100 ×). The FAP score of 4 + or more were defined as high, that of 3 + or less were low; the EGFR expression level of 2 + or 3 + were defined as high, that of 0 or 1 + were low. (C) Survival analysis showed that FAP high patients had significantly worse OS than those with low FAP (P < 0.001, log-rank test; *P < 0.05). (D) Patients with high EGFR tended to show poorer OS than those with low EGFR (P = 0.074, log-rank test). (E) Survival curve of three groups divided by combination of EGFR and FAP scores (double negative, single positive, double positive), double positive group had worse survival than others (P = 0.005: vs. double negative, P = 0.089: vs. single positive, log-rank test; *P < 0.05). Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36418422), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human Fibroblast Activation Protein alpha/FAP Antibody
CyTOF-ready
Flow Cytometry
Sample: WI‑38 human lung fibroblast cell line and U‑87 MG human glioblastoma/astrocytoma cell line
Human Fibroblast Activation Protein alpha/FAP Sandwich Immunoassay
Reviewed Applications
Read 2 reviews rated 5 using MAB3715 in the following applications:
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Fibroblast Activation Protein alpha/FAP
FAP (also known as Seprase) is a 97 kDa Type II transmembrane serine protease that is structurally related to Dipeptidyl Peptidase IV (DPPIV) (1). FAP has substrate specificity similar to DPPIV, which is specific for N-terminal Xaa-Pro sequences, but FAP is also an endopeptidase able to degrade gelatin and Type I Collagen (2). The enzymatically active form of FAP is a dimer that migrates at ~170 kDa. It is associated with multiple integral membrane proteins such as Integrin alpha3 beta1, UPA and DPPIV (3,4). FAP has a restricted tissue distribution. It is occasionally detected in fibroblasts and pancreatic islet cells, but is highly expressed on reactive stromal fibroblasts in epithelial cancers, in granulation tissue during wound healing, and in bone and soft tissue sarcomas (4-6). Because of its expression patterns and enzymatic activities, FAP is believed to play roles in tumor invasion, tissue remodeling, and wound repair. The 760 amino acid (aa) human FAP contains a 735 aa extracellular domain that is glycosylated and necessary for activity (4). It shares 90% aa identity with mouse and rat FAP. A reported 672 aa splicing variant diverges prior to the active site charge relay residues at the C-terminus.
References
- Scanlan, M.J. et al. (1994) Proc. Natl. Acad. Sci. USA 91:5657.
- Park, J.E. et al. (1999) J. Biol. Chem. 274:36505.
- Pineiro-Sanchez, M.L. et al. (1997) J. Biol. Chem. 272:7595.
- O'Brien, P. and B.F. O'Connor (2008) Biochim. Biophys. Acta 1784:1130.
- Garin-Chesa, P. et al. (1990) Proc. Natl. Acad. Sci. USA 87:7235.
- Rettig, W.J. et al. (1988) Proc. Natl. Acad. Sci. USA 85:3110.
Alternate Names
Gene Symbol
UniProt
Additional Fibroblast Activation Protein alpha/FAP Products
- All Products for Fibroblast Activation Protein alpha/FAP
- Fibroblast Activation Protein alpha/FAP cDNA Clones
- Fibroblast Activation Protein alpha/FAP ELISA Kits
- Fibroblast Activation Protein alpha/FAP Lysates
- Fibroblast Activation Protein alpha/FAP Primary Antibodies
- Fibroblast Activation Protein alpha/FAP Proteins and Enzymes
- Fibroblast Activation Protein alpha/FAP Simple Plex
Product Documents for Human Fibroblast Activation Protein alpha/FAP Antibody
Product Specific Notices for Human Fibroblast Activation Protein alpha/FAP Antibody
For research use only